Abstract：Immune checkpoint inhibitors (ICIs) have been widely applied in the clinical treatment of various malignant tumors by blocking the tumor immune escape. However, it is followed by increasing immunerelated adverse events caused by ICIs. As common ICIsrelated cardiovascular adverse reactions, pericardial diseases lead to a relatively high mortality at the acute phase. This article introduces the research progress in recent years on the epidemiology, pathogenesis, clinical characteristics, and treatment principles of ICIsrelated pericardial diseases, in order to deepen the clinicians understandings of this disease.
张舟，罗丹，谭梦琴，王福军. 免疫检查点抑制剂相关心包疾病研究进展[J]. 实用心电学杂志, 2024, 33(6): 553-556.
ZHANG Zhou, LUO Dan, TAN Mengqin, WANG Fujun. Research advances in pericardial diseases associated with immune checkpoint inhibitors. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2024, 33(6): 553-556.
